Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Merck”
Sponsor: Lyvgen Biopharma Holdings Limited
Cancer
United States
- Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)Active Not Recruiting
Sponsor: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Diffuse Cutaneous Systemic Sclerosis · Interstitial Lung Disease
United States, Argentina, Australia, Belgium, Canada +15 more
Sponsor: Dana-Farber Cancer Institute
Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma · Peripheral T-Cell Lymphoma
United States
- Improving Lipid Optimization Quality and Treatment Options in ASCVDEnrolling By Invitation
Sponsor: Brigham and Women's Hospital
Hypercholesterolemia · ASCVD
United States
- Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell LymphomaActive Not Recruiting
Sponsor: University of Southampton
Diffuse Large B Cell Lymphoma
United Kingdom
Sponsor: GI Innovation, Inc.
Advanced Solid Tumor · Metastatic Solid Tumor · Cervical Cancer · Urothelial Carcinoma
United States, South Korea
- Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)Active Not Recruiting
Sponsor: Daiichi Sankyo
Advanced or Metastatic NSCLC
United States, Italy, Japan, Spain, Taiwan
- Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lung Neoplasms · Carcinoma, Non-Small-Cell Lung
United States, Argentina, Canada, Chile, China +21 more
- A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Australia, Brazil, Bulgaria, Canada +27 more
- A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)Active Not Recruiting
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Brazil, Canada, Chile, Colombia +18 more
- Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With EnzalutamideActive Not Recruiting
Sponsor: OHSU Knight Cancer Institute
Castration-Resistant Prostate Carcinoma · Hormone-Resistant Prostate Cancer · PSA Progression · Recurrent Prostate Carcinoma
United States
- Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and AboveActive Not Recruiting
Sponsor: University of Virginia
Classical Hodgkin Lymphoma
United States
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Hepatocellular
United States, Australia, Brazil, Chile, China +22 more
- ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic MalignanciesCompleted
Sponsor: Acerta Pharma BV
Follicular Lymphoma (FL) · CLL · Small Lymphocytic Lymphoma (SLL) · Richter's Syndrome
United States
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
COPD
United States
Sponsor: Merck Sharp & Dohme LLC
Mature B-cell Neoplasms
Japan
Sponsor: Memorial Sloan Kettering Cancer Center
Central Nervous System Tumors · Glioma
United States
Sponsor: Dan Zandberg
HPV-Related Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma
United States
- Combination Study of Guadecitabine/ASTX727 and PembrolizumabActive Not Recruiting
Sponsor: Royal Marsden NHS Foundation Trust
Non Small Cell Lung Cancer
United Kingdom
- Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate CancerActive Not Recruiting
Sponsor: University of Michigan Rogel Cancer Center
Prostate Cancer Metastatic · Neuroendocrine Tumors
United States
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Healthy
United States
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Neurofibromatosis Type 1-Associated Plexiform Neurofibromas · Histiocytic Neoplasm · Other MAP-K Pathway Driven Diseases
Sponsor: Merck Sharp & Dohme LLC
RSV Infection
United States, Australia, Canada, Chile, Colombia +22 more
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Desmoid Tumor · NOTCH Gene Mutation Positive Tumors
- Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial CancerActive Not Recruiting
Sponsor: University of Oklahoma
Endometrial Cancer
United States